Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000949711 | SCV001095975 | likely benign | not provided | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001818953 | SCV002069789 | likely benign | not specified | 2019-03-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002489300 | SCV002798854 | likely benign | Hyperparathyroidism 4; Hypoparathyroidism, familial isolated, 2 | 2021-07-21 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV002489300 | SCV006057099 | likely benign | Hyperparathyroidism 4; Hypoparathyroidism, familial isolated, 2 | 2021-11-16 | criteria provided, single submitter | research | |
Prevention |
RCV003970705 | SCV004786236 | likely benign | GCM2-related disorder | 2022-01-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |